COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed

Nadir Yalcin*, Karel Allegaert

*Corresponding author for this work

Research output: Contribution to journalArticleAcademicpeer-review

17 Citations (Scopus)
6 Downloads (Pure)

Fingerprint

Dive into the research topics of 'COVID-19 and antiepileptic drugs: an approach to guide practices when nirmatrelvir/ritonavir is co-prescribed'. Together they form a unique fingerprint.

Pharmacology, Toxicology and Pharmaceutical Science